Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...
Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal ...
NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi, which the ...
As individuals, we can’t do much about microplastics. A lot of it ends up in the oceans, the fish are ingesting it and we’re ...
Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, ...
The topographical features of DNA in the body may dictate where and when cancer-causing mutations appear in its code. When you purchase through links on our site, we may earn an affiliate commission.
An artificial intelligence model was shown to predict tumor mutation burden in lung cancer and other diseases. GigaPath, an artificial intelligence (AI) model, may predict cancer mutations including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback